United Nations group to meet in Berlin in October 2017 to discuss global issue of Anti-Microbial Resistance

Destiny Pharma plc notes the leading article on the global issue of AMR (anti-microbial resistance) and the accompanying opinion piece in the Observer newspaper on 8th October. The article highlights the upcoming meeting in Berlin on 12th October of the United Nation’s “Antimicrobial Resistance Inter-Agency Coordination Group (IACG)” which is meeting to focus on the most critical gaps in tackling the development and spread of drug-resistant infections, and to commit to concerted and tangible actions.

Dr Bill Love, CSO and founder of Destiny Pharma noted, “Destiny actively supports such initiatives and believes that Destiny’s novel, anti-infective portfolio has the potential to be a breakthrough in the prevention and treatment of certain infections whilst also addressing the global problem of AMR”.

For more information on the Observer article please visit: https://www.theguardian.com/society/2017/oct/08/world-faces-antibiotic-apocalypse-says-chief-medical-officer